CND Chair. Today is the last day of our deliberations. Before we start, it’s wonderful to see you all here again. We had 4 days of productive, engaging discussions, wide-ranging conversations on a wide range of issues. We heard from CSOs and other stakeholders, and you had productive and meaningful deliberations. I will only make …
Guatemala
Plenary — Wednesday afternoon session
Youth Forum: Your excellencies, distinguished delegates, ladies and gentleman. From 25 countries we gather as a unified voice to address the issue of substance use in our communities. This is not a new challenge and has been tackled over the past decades. Everyday there are new substances threatening individuals and society as a whole. It …
Plenary — Wednesday morning session
Item 5. Implementation of the international drug control treaties (continued) (a) Changes in the scope of control of substances Chair: First, Commission will consider recommendations of WHO on 4 substances, namely: (a) Whether or not it wishes to include N-pyrrolidino protonitazene in Schedule I of the 1961 Convention as amended; (b) Whether or not it …
Committee of the Whole (Friday morning)
L2 – Celebrating the tenth anniversary of the United Nations Guiding Principles on Alternative Development: effective implementation and the way forward (Dominican Republic, Germany, Peru, Philippines and Thailand) Chair: Good Morning! Chair: We have two resolutions still to be agreed this morning. I hope we can see good flexibility this morning as in the last …
Item 5. Implementation of the international drug control treaties (Tuesday morning)
Chair: We will consider scheduling recommendations by WHO and INCB. CND Secretariat: Recalls the substances and scheduling recommendations. Chair: Explains process to schedule substances under 1961, 1971 and 1988 conventions. Butonitazene WHO: Butonitazene, or butoxynitazene, is a benzimidazole-derived synthetic opioid not currently under international control and lacking recognized therapeutic use. It appears as a crystalline …
Item 3. High-level segment (Friday morning)
Canada: Esteemed Chair, Ministers, Heads of Delegation, Distinguished Delegates, and Civil Society Representatives: Canada is experiencing one of the most serious public health crises in our country’s history: an unrelenting toxic drug and overdose crisis. The impact and scope of the toxic drug crisis is devastating and more complex than ever. Tragically, we have seen …